These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39415300)

  • 41. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
    Kang KY; Ju JH; Park SH; Hong YS
    J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Posture, balance and gait in axial spondyloarthritis: a case-control study.
    Türk E; Yurdakul FG; Güler T; Bodur H
    Rheumatol Int; 2024 Nov; 44(11):2527-2538. PubMed ID: 39230687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
    Maksymowych WP; Inman RD; Bessette L; Rahman P; Rampakakis E; Asin-Milan O; Rachich M; Marrache AM; Lehman AJ
    Arthritis Res Ther; 2023 Apr; 25(1):70. PubMed ID: 37118833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage.
    López-Medina C; Garrido-Castro JL; Castro-Jiménez J; González-Navas C; Calvo-Gutiérrez J; Castro-Villegas MC; Ortega-Castro R; Escudero-Contreras A; Font-Ugalde P; Collantes-Estévez E
    Clin Rheumatol; 2018 Jun; 37(6):1581-1588. PubMed ID: 29691772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis.
    Fernández-Carballido C; Jovaní V; Catalán EB; Moreno-Ramos MJ; Sanz Sanz J; Gallego A; García Vivar ML; Rodríguez-Heredia JM; Sanabra C; Sastré C
    Front Med (Lausanne); 2022; 9():1078325. PubMed ID: 36619648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis.
    Rabelo CF; Baptista TSA; Petersen LE; Bauer ME; Keiserman MW; Staub HL
    Open Access Rheumatol; 2018; 10():21-25. PubMed ID: 29750059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.
    Braun J; Kiltz U; Baraliakos X; van der Heijde D
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-96-104. PubMed ID: 25365096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis.
    Sari IF; Tatli S; Ilhanli I; Er E; Kasap Z; Çilesizoğlu Yavuz N; Kulakli F
    Cureus; 2023 Jul; 15(7):e42528. PubMed ID: 37637649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
    Sagard J; Olofsson T; Mogard E; Marsal J; Andréasson K; Geijer M; Kristensen LE; Lindqvist E; Wallman JK
    Arthritis Res Ther; 2022 Feb; 24(1):42. PubMed ID: 35151357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
    Gao R
    J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort.
    Mogard E; Olofsson T; Bergman S; Bremander A; Kristensen LE; Olsen JK; Wallman JK; Lindqvist E
    J Rheumatol; 2021 Nov; 48(11):1672-1679. PubMed ID: 33323532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.
    Fong W; Woon TH; Kwan YH; Braun J; van der Heijde D; Boonen A; Kiltz U
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index.
    Di Carlo M; Lato V; Di Matteo A; Carotti M; Salaffi F
    Rheumatol Int; 2017 May; 37(5):713-718. PubMed ID: 28063070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The reliability and validity of a Korean translation of the ASAS Health Index and Environmental Factors in Korean patients with axial spondyloarthritis.
    Choi JH; Kim TJ; Shin K; Choi CB; Kim JH; Kim SH; Kim NI; Ahn MJ; Jung HJ; Lee KE; Park DJ; Park YW; Lee SS; Kim TH
    J Korean Med Sci; 2014 Mar; 29(3):334-7. PubMed ID: 24616580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Balance and falls in axial Spondyloarthritis: a cross sectional study.
    Mewes KB; Longo B; Campos APB; Simioni J; Skare TL
    Acta Reumatol Port; 2019; 44(4):248-253. PubMed ID: 32281612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
    Micheroli R; Hebeisen M; Wildi LM; Exer P; Tamborrini G; Bernhard J; Möller B; Zufferey P; Nissen MJ; Scherer A; Ciurea A;
    Arthritis Res Ther; 2017 Jul; 19(1):164. PubMed ID: 28724442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
    Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
    J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
    Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
    Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study.
    Lubrano E; Perrotta FM; Manara M; D'Angelo S; Ramonda R; Punzi L; Addimanda O; Salvarani C; Marchesoni A
    Rheumatol Ther; 2020 Jun; 7(2):301-310. PubMed ID: 32062827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.